Page 179 of 294: studies 1,781 to 1,790 of 2,939, newest first. Back to the psychedelic-assisted therapy overview
Psychedelic Intersections January 17, 2025 Alex K. Gearin
The spaces where psychedelic experiences unfold are never neutral. Whether in dense forests, urban retreats, or clinical settings, these environments shape how psychedelic senses and emotions are experienced. I propose “psychedelic atmospherics” as a concept to explore the affective and perceptual experience of different settings of psychedelic usage. Psychedelic atmospherics offers a lens for...
PLoS One January 17, 2025 Shakila Meshkat, Wendy Lou, Rakesh Jetly et al. 10 citations
Background Posttraumatic stress disorder (PTSD) affects 3.9% of the general population. While massed cognitive processing therapy (CPT) has demonstrated efficacy in treating chronic PTSD, a substantial proportion of patients still continue to meet PTSD criteria after treatment, highlighting the need for novel therapeutic approaches. Preliminary evidence supports the potential therapeutic action...
Current Pain and Headache Reports January 16, 2025 Isabella Henderson, Ronnie Elsaadany, Gabriel Chan et al. 4 citations
Exploration of the potential of serotonergic psychedelic drugs, such as psilocybin and LSD, as potential treatments for headache disorders. This review addresses the need for well-informed physician guidelines and discusses mechanisms, safety, and efficacy of these treatments. Further research, including the consideration of combination with psychotherapy, is needed. Psychedelics demonstrate...
Addiction January 16, 2025 Noa Krawczyk, Megan Miller, Emma Yuanqi Gu et al. 2 citations
The opioid crisis continues to exert a tremendous toll in North America, with existing interventions often falling short of addressing ongoing needs. Psychedelics are emerging as a possible alternative therapy for mental health and substance use disorders. This study aimed to gather insights on how people use or are considering using psychedelics to manage opioid use disorder (OUD), how these...
Lecture Notes in Education Psychology and Public Media January 15, 2025 Xinna Cai
This paper explores the integration of Buddhist principles, cultivated over 2,500 years for enhancing mental well-being and treating psychological issues, with Western psychology. It builds a bridge between Buddhist conceptssuch as emptiness (nyat), mindfulness, conation (cetan), and loving-kindness and compassionand contemporary psychotherapeutic practices. Although clinical interest has...
Journal of Psychedelic Studies January 15, 2025 Ido Hartogsohn, Yaron Yavelberg, Omry Ben Ezra
Abstract Background and aims The recent resurgence of psychedelic research has led to increased interest in extra-pharmacological factors shaping drug effects (set and setting). Habitually discussed in the context of psychedelic therapy, the relevance of set and setting to determining the outcome of non-psychedelic psychiatric interventions receives strong theoretical and empirical support in...
Journal of Education, Health and Sport January 14, 2025 Wiktoria Podlasiewicz, Paweł Siudziński, Mateusz Łyko et al.
MDMA or 3,4- methylenedioxymethamphetamine is a psychoactive substance, exhibiting mild hallucinogenic properties, that became widely known as a recreational party drug. However, its ability in helping individuals access deeply rooted emotions has prompted significant interest in its potential applications within clinical practice. MDMA’s mechanism of action involves increasing the release of...
The American Journal of Bioethics January 13, 2025 Edward Jacobs
Cheung et al. (2025) rightly argue that psychedelics should be subject to ethical and evidentiary standards consistent with clinical medicine at large, rather than exceptionalism based on their uni...
The American Journal of Bioethics January 13, 2025 Keenan Davis, Roman Palitsky, Boadie W Dunlop et al. 3 citations
In their article “Psychedelic Medicine Exceptionalism,” Cohen and Marks (2025) aim to chart a middle course between two extreme positions—the Scylla and Charybdis of psychedelic “exceptionalism” an...
ACS Medicinal Chemistry Letters January 9, 2025 Robert B. Kargbo
Artificial intelligence (AI) offers transformative potential in psychedelic research by addressing limitations in personalized treatment, predicting therapeutic outcomes, and understanding complex biological and environmental factors. AI-driven models provide new insights into long-term efficacy, set and setting optimization, and alternative treatment methods, advancing psychedelic therapy into...